• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mol Neurobiol . Characterization of Headache in COVID-19: a Retrospective Multicenter Study

tetano

Editor, Senior Moderator
Mol Neurobiol


. 2021 May 25.
doi: 10.1007/s12035-021-02430-w. Online ahead of print.
Characterization of Headache in COVID-19: a Retrospective Multicenter Study


Rafael César Dos Anjos de Paula[SUP] 1 [/SUP], Thaís de Maria Frota Vasconcelos[SUP] 1 [/SUP], Francisco Bruno Santana da Costa[SUP] 1 [/SUP], Lara Albuquerque de Brito[SUP] 2 [/SUP], Danielle Mesquita Torres[SUP] 2 [/SUP], Alissa Elen Formiga Moura[SUP] 2 [/SUP], Danilo Nunes Oliveira[SUP] 1 [/SUP], Guilherme Alves de Lima Henn[SUP] 3 4 [/SUP], Pedro Gustavo Barros Rodrigues[SUP] 1 [/SUP], Isabelle de Sousa Pereira[SUP] 1 [/SUP], Ianna Lacerda Sampaio Braga[SUP] 5 [/SUP], Felipe Araújo Rocha[SUP] 2 [/SUP], Norberto Anízio Ferreira Frota[SUP] 2 6 [/SUP], Fernanda Martins Maia Carvalho[SUP] 2 6 [/SUP], Milena Sales Pitombeira[SUP] 2 [/SUP], José Wagner Leonel Tavares-Junior[SUP] 1 [/SUP], Raquel Carvalho Montenegro[SUP] 7 [/SUP], Pedro Braga-Neto[SUP] 1 8 [/SUP], Paulo Ribeiro Nóbrega[SUP] 9 10 [/SUP], Manoel Alves Sobreira-Neto[SUP] 1 11 [/SUP]



Affiliations

Abstract

Headache is the most common neurological symptom in COVID-19, reported in 6.5 to 34% of patients. Few studies have analyzed its characteristics, and some of them included cases without laboratory confirmation or reported only critical patients. We aimed to analyze the clinical characteristics of COVID-19 associated headache in laboratory-confirmed cases. We conducted a retrospective evaluation of patients with COVID-19 and neurological symptoms. Patients who reported headache answered an interview about its clinical characteristics. Twenty-four patients with COVID-19 associated headache completed the interview. Mean age of patients was 53.8 (standard deviation-17.44), and 14 out of 24 (58.3%) were male. The majority (75%) had no previous history of headache. Fever was documented in 19 out of the 24 patients (79.1%). Headache was predominantly bifrontal or holocranial, in pressure, during hours, worsening with cough or physical activity. COVID-19 headache tends to appear in the first days of symptoms, be either frontal or holocranial and last for days. The quality of pain in pressure and the worsening with cough or physical activity were reported in most cases. We have not found any characteristic that could differentiate COVID-19 associated headache from other causes of headache, possibly because of its multifactorial mechanism.

Keywords: COVID-19; Characterization; Coronavirus; Headache; Neurological symptoms.
 
Back
Top Bottom